Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-25 | New | $19,405,205 | $19,405,205 | Equity and Debt | 06b | SEC link |
| 2022-07-14 | New | $16,514,618 | $16,514,618 | Equity Only | 06b | SEC link |
| 2021-07-09 | New | $70,000,006 | Unknown | Equity Only | SEC link | |
| 2020-05-21 | Amended | $4,849,998 | $1,849,999 | Equity Only | 06b | SEC link |
| 2019-12-06 | New | $2,999,999 | $2,999,999 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Halawa Alaa | Director, Executive |
| Wesley Chan | Director, Executive |
| John De Koning | Director |
| Alaa Halawa | Director |
| David Hsu | Director, Executive |
| Xiling Shen | Director, Executive |
| David Shiaowen | Director |
| William Roy Smythe | Director, Executive |